<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aggressive non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL), including primary central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and non-endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> have been recognized as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-defining <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in most developed countries </plain></SENT>
<SENT sid="1" pm="."><plain>However, HIV/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> epidemics appear not to have been associated with higher incidence of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in Africa </plain></SENT>
<SENT sid="2" pm="."><plain>We therefore carried out this study to highlight the significance or otherwise of HIV/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> epidemics in the pathogenesis of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in a population of Nigerians with the disease </plain></SENT>
<SENT sid="3" pm="."><plain>Since January 1993 to the present, <z:hpo ids='HP_0000001'>all</z:hpo> patients with haematologic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are routinely screened (following appropriate counseling) for <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with a histological diagnosis of malignant <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative diseases</z:e> {non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL), <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (CLL), Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>)} at the Obafemi Awolowo University Teaching Hospitals' Complex, Ile-Ife from January 1993 to August 2008 were noted </plain></SENT>
<SENT sid="5" pm="."><plain>Those patients confirmed to be HIV/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> positive among the cohort with <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were retrospectively studied using their clinical case notes </plain></SENT>
<SENT sid="6" pm="."><plain>Data obtained were analyzed using appropriate descriptive and inferential statistics </plain></SENT>
<SENT sid="7" pm="."><plain>A total of 391 patients were histologically confirmed to have <z:hpo ids='HP_0002665'>lymphoma</z:hpo> {NHL-109, (27.9%); CLL-76, (19.4%); <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-178, (45.5%) and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-28, (7.2%)} during the study period </plain></SENT>
<SENT sid="8" pm="."><plain>Nine patients (2.3%) were confirmed to be HIV- positive, <z:hpo ids='HP_0000001'>all</z:hpo> within the age bracket 24-60 (median = 50) years </plain></SENT>
<SENT sid="9" pm="."><plain>Six of these, five males and one female, ages 24-60 (median = 37.5) years, had NHL while another three, <z:hpo ids='HP_0000001'>all</z:hpo> females (age 50 - 68 years; median = 56 years) had CLL </plain></SENT>
<SENT sid="10" pm="."><plain>None of the patients with <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> were HIV positive </plain></SENT>
<SENT sid="11" pm="."><plain>Patients with NHL presented at advanced stage of the disease (at least clinical stage IIIb), and <z:hpo ids='HP_0000001'>all</z:hpo> those with CLL presented at stage C of the International Working Party Classification </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the HIV-positive patients with NHL succumbed to the disease within one to three weeks of admission into the hospital </plain></SENT>
<SENT sid="13" pm="."><plain>The prevalence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-related <z:hpo ids='HP_0002665'>lymphomas</z:hpo> is 2.3% compared to 4.4% found in the general population </plain></SENT>
<SENT sid="14" pm="."><plain>However, it is interesting that no single case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-associated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> was seen, despite the fact that Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is endemic in this part of the world </plain></SENT>
<SENT sid="15" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the patients presented at a very advanced stage of the disease with significantly shortened survival </plain></SENT>
</text></document>